Description
Evorel Conti Patches are a continuous hormone replacement therapy (HRT) designed for postmenopausal women who no longer have a regular menstrual cycle. These transdermal patches deliver a combined dose of estradiol (a form of oestrogen) and norethisterone (a synthetic progestogen) to help relieve common menopause symptoms caused by hormonal decline.
During menopause, the body’s natural production of oestrogen decreases, often leading to hot flushes, mood changes, disrupted sleep, and vaginal dryness. Evorel Conti patches restore hormonal balance, helping to ease these symptoms and improve overall quality of life.
Each patch provides a consistent dose of hormones absorbed through the skin and into the bloodstream. The continuous regimen includes both oestrogen and progestogen to reduce the risk of endometrial thickening, making it suitable for women who still have their uterus.
How Evorel Conti Patches Work
When applied to the lower back, abdomen, or buttocks, the patch releases hormones gradually over several days. This avoids the hormone spikes often seen with oral tablets. You wear each patch for three to four days, then replace it with a new one — maintaining round-the-clock hormone delivery.
The steady hormone absorption helps reduce fluctuations that can trigger symptoms, while offering a convenient and effective way to manage menopause long term.
Why Choose Evorel Conti Patches
Evorel Conti patches are discreet, simple to use, and require only twice-weekly changes. They avoid first-pass liver metabolism, which makes them ideal for women who can’t tolerate oral HRT. Many users report fewer side effects and greater comfort compared to tablet-based therapies.
Additionally, the patches can help support bone density, reduce hot flushes, and improve sleep quality — benefits that are especially valuable during later stages of menopause.
Important Note
Rotate application sites with each patch change. Do not apply to the breasts. Always follow your prescriber’s instructions and attend regular HRT reviews.
